Carcinoma embryonic antigen: Its place in decision making for pulmonary metastasectomy in colorectal cancer

Journal of Thoracic Oncology

Volumn 5, Issue 6 SUPPL. 2, 2010, Pages

  Treasure, Tom ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

CANCER RECURRENCE; CLINICAL DECISION MAKING; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; LUNG METASTASIS; LUNG RESECTION; MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SURVIVAL; BLOOD; COLORECTAL TUMOR; DECISION MAKING; LUNG NEOPLASMS; PATHOLOGY; SECONDARY;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DECISION MAKING; HUMANS; LUNG NEOPLASMS; PNEUMONECTOMY;

EID: 77953169091     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181dca251     Document Type: Article

References (13)

1. Pfannschmidt J, Hoffman H, Dienemann H. Factors influencing outcome of pulmonary metastasectomy for colorectal cancer. J Thorac Oncol. In press.
2. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 2002;124:1007-1013.
3. Kanemitsu Y, Kato T, Hirai T, et al. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 2004;91:112-120.
4. Onaitis MW, Petersen RP, Haney JC, et al. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg 2009;87:1684-1688.
5. Utley M, Treasure T. The use of scoring systems in selecting patients for lung resection: work-up bias comes full-circle. Thorac Surg Clin 2008;18:107-112.
6. Treasure T, Utley M, Berrisford R. A risk model for lung resection: data from the European Thoracic Database Project. Eur J Anaesthesiol 2008;25:613-619.
7. Fiorentino F, Hunt I, Teoh K, et al. Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med. 2010;103:60-66.
8. Treasure T, Fallowfield L, Farewell V, et al. Pulmonary metastasectomy in colorectal cancer: time for a trial. Eur J Surg Oncol 2009;35:686-689.
9. Treasure T, Lees B, Fallowfield L. An exemplar trial in metastasectomy: PulMiCC (Pulmonary Metastasectomy in Colorectal Cancer). J Thorac Oncol. In press.
10. Northover J, Houghton J, Lennon T. CEA to detect recurrence of colon cancer. JAMA 1994;272:31.
11. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-1410.
12. Virgo KS, Wade TP, Longo WE, et al. Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists. Ann Surg Oncol 1995;2:472-482.
13. Virgo KS, Vernava AM, Longo WE, et al. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995;273:1837-1841.